Home/ Stocks/ MIRA

MIRA Pharmaceuticals, Inc. Common Stock

MIRA XNAS

$0.74 +0.06 (+9.11%) ▲ 15-min delayed

Open

$0.68

High

$0.75

Low

$0.67

Volume

156.4K

Market Cap

$28.50M

About MIRA Pharmaceuticals, Inc. Common Stock

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 2 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	N/A	$-1,150,152	$-0.03
FY 2025	N/A	$-10,442,485	$-1.35
Q3 2025	N/A	$-1,137,673	$-1.18
Q2 2025	N/A	$-1,537,712	$-0.09

Related Market News

No specific coverage for MIRA yet. Check out our latest market news or earnings calendar.

Get MIRA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on MIRA Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.